Case Study - Kenneth B

Ken's key disease markers have seen a 45% reduction through Terry's treatment methods

The Patient

Kenneth B is a 76 year old male who was diagnosed with smoldering myeloma (SMM) in 2006 at the age of 63. He entered our study in 2010. When Ken first entered the study, his paraprotein level was 31.7 grams per litre and his free light chain ratio was 0.3. These are two of the key disease markers for patients with SMM. 

Treatment & Results

Since 2010 Ken has been taking curcumin daily and his disease markers have shown a steady  improvement or remained stable over the years. His paraprotein level as of January 2020 was 17.7 grams per litre – a 44% reduction in paraprotein over a 10 year period. His free light chain ratio as of January 2020 remains at 0.3 - within the normal range of 0.3-1.7.

What it Means for Kenneth

For patients like Ken (with SMM), there is a 50% chance that the disease would have progressed to Multiple Myeloma - a very aggressive type of cancer - within 5 years.  However, with curcumin intervention not only has Kenneth not progressed after 10 years, but his disease markers have actually improved. 

 

Below is a chart of Ken's paraprotein level over a 10 year period: 

Book a consultation now with Terry to start your MGUS/SMM Therapy

Contact Me 

MGUS Therapy
Sydney, Australia

Linkedin.png

© 2020 by MGUS Therapy

Disclaimer

The information contained in this site is intended to provide helpful health information. While the site managers have exercised due care in ensuring the accuracy of the material contained on this website, the information is made available on the understanding that the site managers are not providing professional advice on a particular matter. Nothing contained in this site is intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professional's advice. Before relying on the material in any important matter, users should carefully evaluate its accuracy, currency, completeness and relevance for their purposes, and should obtain any appropriate professional advice relevant to their particular circumstances. In some cases the material may incorporate or summarise views, guidelines or recommendations of third parties. Such material is assembled in good faith, but does not necessarily reflect the considered views of the site managers, or indicate a commitment to a particular course of action. The site managers do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information provided on this website.